Results 181 to 190 of about 52,475 (270)

Safety and efficacy of continuous periprocedural rivaroxaban for patients undergoing catheter ablation procedures: a retrospective registry analysis [PDF]

, 2013
Roger Dillier, S. Ammar, Tilko Reents, Herribert Pavaci, Alessandra Buiatti, Verena Semmler, Carsten Lennerz, Christof Kolb, Gabriele Hessling, Isabel Deisenhofer   +9 more
openalex   +1 more source

Direct oral anticoagulant rivaroxaban for secondary prevention of catheter-related thrombosis in children with intestinal failure: real-life data. [PDF]

Res Pract Thromb Haemost
Hilberath J, Ballauff A, Rückel A, Sieverding L, Vermeulen D, Eberl W, Hartleif S, Lieber J, Michel J, Sturm E, Nordmeyer J, Icheva V.   +11 more
europepmc   +1 more source

Impact of NSAID Use on Bleeding Rates for Patients Taking Rivaroxaban or Apixaban.

Rebecca Worsham, R. Darren Wood, Alan Radford   +2 more
openalex   +2 more sources

Análisis coste-efectividad y coste-utilidad de apixaban frente a dabigatrán y rivaroxaban en el tratamiento y prevención secundaria del tromboembolismo venoso [PDF]

, 2017
F. de Andrés-Nogales, Itziar Oyagüez, Luis A. Álvarez-Sala, F García‐Bragado, Andrés Navarro‐Ruiz, Paloma González, Isabel Elías, Javier Soto   +7 more
openalex   +1 more source

Trends and Hot Spots in Research Related to Rivaroxaban: Bibliometric Analysis. [PDF]

Clin Pract
Pawlak K, Kruszyna Ł, Wesołowska A, Karaźniewicz-Łada M.   +3 more
europepmc   +1 more source

Conception of a Personalized Medication Adherence Discharge Kit for Rivaroxaban

, 2016
Gretchen Stern, Jamie M. Pitlick, Zachary A. Stacy, Andrew J. Crannage   +3 more
openalex   +2 more sources

Molecular basis of water sorption behaviour of rivaroxaban–malonic acid cocrystal [PDF]

, 2019
Dnyaneshwar P. Kale, Bharat Ugale, C. M. Nagaraja, Gurudutt Dubey, Prasad V. Bharatam, Arvind K. Bansal   +5 more
openalex   +1 more source

Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD. [PDF]

J Am Heart Assoc
Hogan S, Szarek M, Debus ES, Nehler M, Anand SS, Patel MR, Pap AF, Deng H, Hodge S, Haskell LP, Muehlhofer E, Berkowitz SE, Bauersachs RM, Bonaca MP.   +13 more
europepmc   +1 more source

Development of a Paediatric Population-Based Model of the Pharmacokinetics of Rivaroxaban [PDF]

, 2013
Stefan Willmann, Corina Becker, Rolf Burghaus, Katrin Coboeken, Andrea N. Edginton, Jörg Lippert, Hans‐Ulrich Siegmund, Kirstin Thelen, Wolfgang Mück   +8 more
openalex   +1 more source

Comparative effectiveness and pharmacological fingerprints of indobufen versus rivaroxaban in patients with chronic kidney disease: a single-center, real-world study. [PDF]

Front Pharmacol
Zhang L, Liu M, Huang T, Zhang H, Huang C, Pan Z, Chen Z, Ning J, Tang J.   +8 more
europepmc   +1 more source